Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from IO Biotech ( (IOBT) ).
On December 17, 2025, IO Biotech, Inc. received a notice from Nasdaq that its common stock no longer met the Nasdaq Global Select Market’s minimum bid price requirement, as its closing bid price had remained below $1.00 per share for 30 consecutive trading days, though the stock continues to trade without immediate impact to its listing status. The company has until June 16, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive trading days, and while it may seek an additional 180-day compliance period through a transfer to the Nasdaq Capital Market, failure to cure the deficiency could ultimately result in delisting, introducing heightened uncertainty for shareholders and potentially constraining the company’s access to capital markets.
The most recent analyst rating on (IOBT) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on IO Biotech stock, see the IOBT Stock Forecast page.
Spark’s Take on IOBT Stock
According to Spark, TipRanks’ AI Analyst, IOBT is a Neutral.
IO Biotech faces significant challenges due to its financial instability and lack of revenue. However, the progress in clinical trials and secured financing improve its future prospects, though it remains speculative. The technical analysis suggests neutral momentum, and the valuation highlights typical risks associated with biotech stocks awaiting commercialization.
To see Spark’s full report on IOBT stock, click here.
More about IO Biotech
IO Biotech, Inc. is a biotechnology company whose common stock is listed on the Nasdaq Global Select Market, giving it access to public equity markets and subjecting it to Nasdaq’s continued listing standards, including minimum bid price requirements.
Average Trading Volume: 3,671,470
Technical Sentiment Signal: Sell
Current Market Cap: $45.68M
See more insights into IOBT stock on TipRanks’ Stock Analysis page.